Type 1 diabetes: fewer complications with intensive insulin therapy.

Journal: Prescrire international 2014;22(142):249

PMID: 24298600

Abstract

Extended follow-up of participants in the "DCCT" trial showed that, in type 1 diabetes, aiming for near-physiological blood glucose concentrations from the start of therapy reduces the risk of diabetic retinopathy, cardiovascular complications and renal impairment.

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.